SCH-412499

N/A

Report date: 2023/10/26 16:14:33

Base Information

Drug NameSCH-412499
Drug Alias NameSCH-412499rAD-p21
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSchering - Plough Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering - Plough Sa
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A